289 related articles for article (PubMed ID: 21533148)
21. Extracellular Hsp90α Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer.
Hou Q; Chen S; An Q; Li B; Fu Y; Luo Y
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299365
[TBL] [Abstract][Full Text] [Related]
22. Secreted heat shock protein 90α (HSP90α) induces nuclear factor-κB-mediated TCF12 protein expression to down-regulate E-cadherin and to enhance colorectal cancer cell migration and invasion.
Chen WS; Chen CC; Chen LL; Lee CC; Huang TS
J Biol Chem; 2013 Mar; 288(13):9001-10. PubMed ID: 23386606
[TBL] [Abstract][Full Text] [Related]
23. CERS2 suppresses tumor cell invasion and is associated with decreased V-ATPase and MMP-2/MMP-9 activities in breast cancer.
Fan SH; Wang YY; Lu J; Zheng YL; Wu DM; Zhang ZF; Shan Q; Hu B; Li MQ; Cheng W
J Cell Biochem; 2015 Apr; 116(4):502-13. PubMed ID: 25213553
[TBL] [Abstract][Full Text] [Related]
24. Bovine Hemoglobin Derived Peptide Asn-Phe-Gly-Lys Inhibits Pancreatic Cancer Cells Metastasis by Targeting Secreted Hsp90α.
Wang Y; Zhang T; Zhang H; Yang H; Li Y; Jiang Y
J Food Sci; 2017 Dec; 82(12):3005-3012. PubMed ID: 29083493
[TBL] [Abstract][Full Text] [Related]
25. Transactivation of the epidermal growth factor receptor by heat shock protein 90 via Toll-like receptor 4 contributes to the migration of glioblastoma cells.
Thuringer D; Hammann A; Benikhlef N; Fourmaux E; Bouchot A; Wettstein G; Solary E; Garrido C
J Biol Chem; 2011 Feb; 286(5):3418-28. PubMed ID: 21127066
[TBL] [Abstract][Full Text] [Related]
26. Chaperone Activity and Dimerization Properties of Hsp90
Morishima Y; Mehta RK; Yoshimura M; Lau M; Southworth DR; Lawrence TS; Pratt WB; Nyati MK; Osawa Y
Mol Pharmacol; 2018 Sep; 94(3):984-991. PubMed ID: 29941666
[TBL] [Abstract][Full Text] [Related]
27. Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding.
Butler GS; Dean RA; Tam EM; Overall CM
Mol Cell Biol; 2008 Aug; 28(15):4896-914. PubMed ID: 18505826
[TBL] [Abstract][Full Text] [Related]
28. Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways.
Zhou R; Xu L; Ye M; Liao M; Du H; Chen H
Horm Metab Res; 2014 Oct; 46(11):753-60. PubMed ID: 24977660
[TBL] [Abstract][Full Text] [Related]
29. PTHrP [67-86] regulates the expression of stress proteins in breast cancer cells inducing modifications in urokinase-plasminogen activator and MMP-1 expression.
Luparello C; Sirchia R; Pupello D
J Cell Sci; 2003 Jun; 116(Pt 12):2421-30. PubMed ID: 12724357
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of heat shock protein (Hsp) 27 potentiates the suppressive effect of Hsp90 inhibitors in targeting breast cancer stem-like cells.
Lee CH; Hong HM; Chang YY; Chang WW
Biochimie; 2012 Jun; 94(6):1382-9. PubMed ID: 22445681
[TBL] [Abstract][Full Text] [Related]
31. Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway.
Xu L; Bergan RC
Mol Pharmacol; 2006 Sep; 70(3):869-77. PubMed ID: 16772519
[TBL] [Abstract][Full Text] [Related]
32. Heat-shock protein 90α protects NME1 against degradation and suppresses metastasis of breast cancer.
Zhang Y; Zhao G; Yu L; Wang X; Meng Y; Mao J; Fu Z; Yin Y; Li J; Wang X; Guo C
Br J Cancer; 2023 Nov; 129(10):1679-1691. PubMed ID: 37731021
[TBL] [Abstract][Full Text] [Related]
33. A potentially common peptide target in secreted heat shock protein-90α for hypoxia-inducible factor-1α-positive tumors.
Sahu D; Zhao Z; Tsen F; Cheng CF; Park R; Situ AJ; Dai J; Eginli A; Shams S; Chen M; Ulmer TS; Conti P; Woodley DT; Li W
Mol Biol Cell; 2012 Feb; 23(4):602-13. PubMed ID: 22190738
[TBL] [Abstract][Full Text] [Related]
34. Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness.
Eustace BK; Sakurai T; Stewart JK; Yimlamai D; Unger C; Zehetmeier C; Lain B; Torella C; Henning SW; Beste G; Scroggins BT; Neckers L; Ilag LL; Jay DG
Nat Cell Biol; 2004 Jun; 6(6):507-14. PubMed ID: 15146192
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus X protein upregulates HSP90alpha expression via activation of c-Myc in human hepatocarcinoma cell line, HepG2.
Li W; Miao X; Qi Z; Zeng W; Liang J; Liang Z
Virol J; 2010 Feb; 7():45. PubMed ID: 20170530
[TBL] [Abstract][Full Text] [Related]
36. Hsp90 C-terminal inhibitors exhibit antimigratory activity by disrupting the Hsp90α/Aha1 complex in PC3-MM2 cells.
Ghosh S; Shinogle HE; Garg G; Vielhauer GA; Holzbeierlein JM; Dobrowsky RT; Blagg BS
ACS Chem Biol; 2015 Feb; 10(2):577-90. PubMed ID: 25402753
[TBL] [Abstract][Full Text] [Related]
37. HSP90 modulates actin dynamics: inhibition of HSP90 leads to decreased cell motility and impairs invasion.
Taiyab A; Rao ChM
Biochim Biophys Acta; 2011 Jan; 1813(1):213-21. PubMed ID: 20883729
[TBL] [Abstract][Full Text] [Related]
38. Casticin inhibits breast cancer cell migration and invasion by down-regulation of PI3K/Akt signaling pathway.
Fan L; Zhang Y; Zhou Q; Liu Y; Gong B; Lü J; Zhu H; Zhu G; Xu Y; Huang G
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30401729
[TBL] [Abstract][Full Text] [Related]
39. Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2.
Lee YC; Chang WW; Chen YY; Tsai YH; Chou YH; Tseng HC; Chen HL; Wu CC; Chang-Chien J; Lee HT; Yang HF; Wang BY
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914785
[TBL] [Abstract][Full Text] [Related]
40. Resveratrol inhibits migration and invasion of human breast-cancer cells.
Tang FY; Su YC; Chen NC; Hsieh HS; Chen KS
Mol Nutr Food Res; 2008 Jun; 52(6):683-91. PubMed ID: 18398872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
